Tian-Lu Cheng
9PUBLICATIONS
8CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (9)
Sort by Publication Date:
|Oct 01, 2025
Spatial-hindrance-based pro-Adalimumab prevents anti-idiotypic antibody interference in pharmacokinetic and therapeutic efficacy.Bo-Cheng Huang, Yu-Tung Chen, Yun-Chi Lu
|Dec 12, 2024
Impact of Pre-existing Anti-polyethylene Glycol Antibodies on the Pharmacokinetics and Efficacy of a COVID-19 mRNA Vaccine (Comirnaty) In Vivo.Yen-Ling Liu, Tzu-Yi Liao, Kai-Wen Ho
|Aug 15, 2024
Integrating molecular dynamics simulation with small- and wide-angle X-ray scattering to unravel the flexibility, antigen-blocking, and protease-restoring functions in a hindrance-based pro-antibody.Jun Min Liao, Shih-Ting Hong, Yeng-Tseng Wang
|Feb 01, 2022
A universal in silico V(D)J recombination strategy for developing humanized monoclonal antibodies.Yuan-Chin Hsieh, Jun-Min Liao, Kuo-Hsiang Chuang
|Aug 05, 2021
Development of a structure-based computational simulation to optimize the blocking efficacy of pro-antibodies.Bo-Cheng Huang, Yun-Chi Lu, Jun-Min Liao
|Jan 10, 2021
Double attack strategy for leukemia using a pre-targeting bispecific antibody (CD20 Ab-mPEG scFv) and actively attracting PEGylated liposomal doxorubicin to enhance anti-tumor activity.Kai-Wen Ho, I-J U Chen, Yi-An Cheng
Pageof 2
